Cargando…

Regression based predictor for p53 transactivation

BACKGROUND: The p53 protein is a master regulator that controls the transcription of many genes in various pathways in response to a variety of stress signals. The extent of this regulation depends in part on the binding affinity of p53 to its response elements (REs). Traditional profile scores for...

Descripción completa

Detalles Bibliográficos
Autores principales: Gowrisankar, Sivakumar, Jegga, Anil G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719629/
https://www.ncbi.nlm.nih.gov/pubmed/19602281
http://dx.doi.org/10.1186/1471-2105-10-215
_version_ 1782170081122320384
author Gowrisankar, Sivakumar
Jegga, Anil G
author_facet Gowrisankar, Sivakumar
Jegga, Anil G
author_sort Gowrisankar, Sivakumar
collection PubMed
description BACKGROUND: The p53 protein is a master regulator that controls the transcription of many genes in various pathways in response to a variety of stress signals. The extent of this regulation depends in part on the binding affinity of p53 to its response elements (REs). Traditional profile scores for p53 based on position weight matrices (PWM) are only a weak indicator of binding affinity because the level of binding also depends on various other factors such as interaction between the nucleotides and, in case of p53-REs, the extent of the spacer between the dimers. RESULTS: In the current study we introduce a novel in-silico predictor for p53-RE transactivation capability based on a combination of multidimensional scaling and multinomial logistic regression. Experimentally validated known p53-REs along with their transactivation capabilities are used for training. Through cross-validation studies we show that our method outperforms other existing methods. To demonstrate the utility of this method we (a) rank putative p53-REs of target genes and target microRNAs based on the predicted transactivation capability and (b) study the implication of polymorphisms overlapping p53-RE on its transactivation capability. CONCLUSION: Taking into account both nucleotide interactions and the spacer length of p53-RE, we have created a novel in-silico regression-based transactivation capability predictor for p53-REs and used it to analyze validated and novel p53-REs and to predict the impact of SNPs overlapping these elements.
format Text
id pubmed-2719629
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27196292009-08-01 Regression based predictor for p53 transactivation Gowrisankar, Sivakumar Jegga, Anil G BMC Bioinformatics Methodology Article BACKGROUND: The p53 protein is a master regulator that controls the transcription of many genes in various pathways in response to a variety of stress signals. The extent of this regulation depends in part on the binding affinity of p53 to its response elements (REs). Traditional profile scores for p53 based on position weight matrices (PWM) are only a weak indicator of binding affinity because the level of binding also depends on various other factors such as interaction between the nucleotides and, in case of p53-REs, the extent of the spacer between the dimers. RESULTS: In the current study we introduce a novel in-silico predictor for p53-RE transactivation capability based on a combination of multidimensional scaling and multinomial logistic regression. Experimentally validated known p53-REs along with their transactivation capabilities are used for training. Through cross-validation studies we show that our method outperforms other existing methods. To demonstrate the utility of this method we (a) rank putative p53-REs of target genes and target microRNAs based on the predicted transactivation capability and (b) study the implication of polymorphisms overlapping p53-RE on its transactivation capability. CONCLUSION: Taking into account both nucleotide interactions and the spacer length of p53-RE, we have created a novel in-silico regression-based transactivation capability predictor for p53-REs and used it to analyze validated and novel p53-REs and to predict the impact of SNPs overlapping these elements. BioMed Central 2009-07-14 /pmc/articles/PMC2719629/ /pubmed/19602281 http://dx.doi.org/10.1186/1471-2105-10-215 Text en Copyright © 2009 Gowrisankar and Jegga; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Gowrisankar, Sivakumar
Jegga, Anil G
Regression based predictor for p53 transactivation
title Regression based predictor for p53 transactivation
title_full Regression based predictor for p53 transactivation
title_fullStr Regression based predictor for p53 transactivation
title_full_unstemmed Regression based predictor for p53 transactivation
title_short Regression based predictor for p53 transactivation
title_sort regression based predictor for p53 transactivation
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719629/
https://www.ncbi.nlm.nih.gov/pubmed/19602281
http://dx.doi.org/10.1186/1471-2105-10-215
work_keys_str_mv AT gowrisankarsivakumar regressionbasedpredictorforp53transactivation
AT jeggaanilg regressionbasedpredictorforp53transactivation